Практические вопросы, касающиеся использования томографии оптической согласованности в многоразовом склерозе в Латинской Америке: обсуждение 19 центров от имени Исследовательской группы по ЭМ Форо Латама.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ciampi Ethel, García Lorena, Carcamo Claudia, Soler Bernardita, Becker Jefferson, Carra Adriana, Correa-Díaz Edgar, Cortés Fernando, Garcia Bonitto Juan, Guerra Carolina, Macias Miguel Angel, Martinez Alejandra, Novarro Nelson, Rivera-Sarabia Linda, Rocha Valeria, Rodriguez Virginia, Sato Douglas, Steinberg Judith, Treviño Frenk Irene, Vasquez Guido, Peña Luis
Аннотация
Оригинал публикации
Practical issues concerning the use of optical coherence tomography in multiple sclerosis in Latin America: Discussion from 19 centres on behalf of the Foro Latam EM study group.
The 2024 McDonald Criteria now include the optic nerve as the fifth topography for dissemination in space. Optical coherence tomography (OCT) is a valuable biomarker for the diagnosis, prognosis and monitoring of multiple sclerosis (MS). A panel of MS neurologists from 19 centres across 9 Latin American (LATAM) countries discussed OCT use, access, standardized protocols and research potential. They found inequities in OCT access between private (80%) and public healthcare (44%). Only 9 centres had standardized protocols, 50% of which followed the OSCAR-IB consensus criteria for retinal OCT quality assessment and 53% had a neuro-ophthalmologist. The panel concluded that OCT should be available in all MS centres and that standardized acquisition and reporting, as well as improved knowledge of OCT use, in clinical practice are necessary. OCT has significant research potential in LATAM that requires further development and implementation.